HomeNewsBusinessGST collection for May at Rs 1.02 lakh crore, 27.6% lower month-on-month

GST collection for May at Rs 1.02 lakh crore, 27.6% lower month-on-month

The May GST collections saw a 27.6 per cent drop from record sum of Rs 1.41 lakh crore in April, which was the highest monthly collection since the introduction of the nationwide tax.

June 06, 2021 / 09:04 IST
Story continues below Advertisement
Representative image
Representative image

The Goods and Service Tax Collection for the month of May came in at Rs 1.02 lakh crore, official data by the Finance Ministry showed on June 5. While this was the eighth consecutive month of GST collections being above Rs 1 lakh crore, it was also the lowest collection since September 2020.

The May GST collections were also a 27.6 per cent drop from record sum of Rs 1.41 lakh crore in April, which was the highest monthly collection since the introduction of the nationwide tax.

Story continues below Advertisement

The gross GST revenue for the month of May, includes a collection of Rs 17,592 crore in form of Central GST, Rs 22,653 crore State GST and Rs 53,199 crore Integrated GST (including Rs 26,002 crore collected on import of goods), said a statement.

“It is good to see that despite the aggressive second COVID wave, the GST collections have remained upward of the 1 lakh crores mark for the eight straight month. Also the dip in comparison to the collections in the previous months was expected as these GST collections are for the supplies made in April, when part of the country was in lockdown,” said Abhishek Jain, Tax Partner, EY.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show